These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 23442798)
21. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer. Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832 [TBL] [Abstract][Full Text] [Related]
22. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer. Zhang P; Zhang P; Shi B; Zhou M; Jiang H; Zhang H; Pan X; Gao H; Sun H; Li Z Cell Death Dis; 2014 Jan; 5(1):e991. PubMed ID: 24407244 [TBL] [Abstract][Full Text] [Related]
23. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer. Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277 [TBL] [Abstract][Full Text] [Related]
24. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer. Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081 [TBL] [Abstract][Full Text] [Related]
25. Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis. Xia D; Yang X; Liu W; Shen F; Pan J; Lin Y; Du N; Sun Y; Xi X Biochem Biophys Res Commun; 2017 Apr; 486(1):191-197. PubMed ID: 28286267 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1. Xu L; Li H; Su L; Lu Q; Liu Z Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. Wen N; Wang Y; Wen L; Zhao SH; Ai ZH; Wang Y; Wu B; Lu HX; Yang H; Liu WC; Li Y J Transl Med; 2014 May; 12():134. PubMed ID: 24885308 [TBL] [Abstract][Full Text] [Related]
29. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872 [TBL] [Abstract][Full Text] [Related]
30. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Zhang C; Li Y; Zhao W; Liu G; Yang Q Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655 [TBL] [Abstract][Full Text] [Related]
31. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer. Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831 [TBL] [Abstract][Full Text] [Related]
32. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459 [TBL] [Abstract][Full Text] [Related]
33. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9. Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653 [TBL] [Abstract][Full Text] [Related]
35. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy. Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival. Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362 [TBL] [Abstract][Full Text] [Related]
37. Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion. Browne G; Taipaleenmäki H; Bishop NM; Madasu SC; Shaw LM; van Wijnen AJ; Stein JL; Stein GS; Lian JB J Cell Physiol; 2015 Oct; 230(10):2522-32. PubMed ID: 25802202 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of HOXC8 is Associated With Poor Prognosis in Epithelial Ovarian Cancer. Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Qian L; Shao M; Mao G Reprod Sci; 2016 Jul; 23(7):944-54. PubMed ID: 26763553 [TBL] [Abstract][Full Text] [Related]
39. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499 [TBL] [Abstract][Full Text] [Related]
40. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells. Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]